Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2025)
Scinai Immunotherapeutics (SCNI) posted Current Leases of $329000.0 for Q4 2025, down 33.8% sequentially from $497000.0 in Q2 2025, and down 22.41% YoY from $424000.0 in Q4 2024.
Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2025) Analysis & Trends
Scinai Immunotherapeutics has reported Current Leases for 7 years, with the latest figure at $329000.0 in Q4 2025.
- Quarterly Current Leases fell 22.41% year-over-year to $329000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $329000.0 (down 22.41% YoY) and the FY2025 annual result came in at $329000.0, down 22.41% from the prior year.
- Current Leases retreated to $329000.0 in Q4 2025 per SCNI's latest filing, from $497000.0 in the prior quarter.
- Over five years, Current Leases peaked at $773000.0 in Q4 2021 and troughed at $241000.0 in Q3 2021.
- A 5-year average of $404500.0 and a median of $388000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2022: Current Leases surged 280.79% in 2021, then slumped 50.58% in 2022.
- Over 5 years, Current Leases stood at $773000.0 in 2021, then plunged by 50.58% to $382000.0 in 2022, then increased by 3.66% to $396000.0 in 2023, then increased by 7.07% to $424000.0 in 2024, then slipped by 22.41% to $329000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $329000.0, $497000.0, and $424000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Scinai Immunotherapeutics | 1.08 Mn | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 329,000.00 |
| Jun 30, 2025 | 497,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Jun 30, 2023 | 394,000.00 |
| Dec 31, 2022 | 382,000.00 |
| Jun 30, 2022 | 245,000.00 |
| Dec 31, 2021 | 773,000.00 |
| Sep 30, 2021 | 241,000.00 |
| Dec 31, 2020 | 203,000.00 |
| Sep 30, 2020 | 190,000.00 |
| Jun 30, 2020 | 195,000.00 |
| Dec 31, 2019 | 201,000.00 |